'Deadly Risk' of Fat-Loss Drugs
Newsweek US|March 22, 2024
Diabetes treatment Ozempic has become popular among dieters due to its weightloss side effect, but a study warns of a link between the drug and suicidal thoughts
PANDORA DEWAN
'Deadly Risk' of Fat-Loss Drugs

"MIRACLE" FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned.

The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2 diabetes, but it has gained popularity and gone viral on social media due to one sought-after side effect: weight loss.

Ozempic is based on a naturally occurring human hormone called glucagon-like peptide 1, which plays an important role in regulating appetite and blood sugar levels. Its active ingredient is a molecule called semaglutide, which mimics the structure of this GLP-1 hormone and activates its receptors.

In doing so, semaglutide induces feelings of fullness while delaying the emptying of our stomach, making us less hungry and therefore less likely to overeat.

Semaglutide is also used in Ozempic's sister drug, Wegovy, which has been approved by the FDA for chronic weight management. Between the start of 2020 and the end of 2022, prescriptions of GLP-1 mimic medications like semaglutide increased by 300 percent across the U.S., according to health care analytics firm Trilliant Health.

The drug has since been endorsed by celebrities and influencers, with #ozempic reaching over 1.4 billion views on TikTok. However, when used as a weight-loss drug, semaglutide has been shown to have some uncomfortable side effects.

Most studies into these have focused on gut problems, but a new study, published in the International Journal of Clinical Pharmacy, has highlighted a concerning association between semaglutide and adverse psychiatric events, including depression, anxiety and suicidal thoughts. Pharmaceutical manufacturer Novo Nordisk, which produces Ozempic and Wegovy, cited the FDA saying that no evidence was found regarding suicidal thoughts or actions caused by these medicines.

Diese Geschichte stammt aus der March 22, 2024-Ausgabe von Newsweek US.

Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.

Diese Geschichte stammt aus der March 22, 2024-Ausgabe von Newsweek US.

Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.

WEITERE ARTIKEL AUS NEWSWEEK USAlle anzeigen
Margo Martindale
Newsweek US

Margo Martindale

Jamie Lee [Curtis, producer] called me and she says, \"Jamie Lee Curtis here. I have a project for you. And you're gonna do it.\"

time-read
1 min  |
December 20, 2024
Malala Yousafzai
Newsweek US

Malala Yousafzai

\"AFGHANISTAN IS THE ONLY COUNTRY IN THE world where girls are banned from access to education and women are limited from work.\"

time-read
1 min  |
December 20, 2024
In the Eyes of the Law
Newsweek US

In the Eyes of the Law

Jude Law is unrecognizable as an FBI agent on the trail of aneo-Naziterrorist group in real-crime drama The Order

time-read
4 Minuten  |
December 20, 2024
Gonzo Intelligence
Newsweek US

Gonzo Intelligence

Instead of keeping a low profile, Moscow's spies are embracing the limelight and even being welcomed home by Vladimir Putin after their cover is blown

time-read
7 Minuten  |
December 20, 2024
House of Cards
Newsweek US

House of Cards

Donald Trump faces negotiations between Saudi Arabia and the U.S. in his second term—could his legacy of normalizing ties between Israel and Arab nations be a help or hindrance?

time-read
10+ Minuten  |
December 20, 2024
AMERICA'S Most Responsible Companies 2025
Newsweek US

AMERICA'S Most Responsible Companies 2025

IN THE FACE OF ISSUES LIKE CLIMATE CHANGE and wage inequality, consumers care about the impact of the businesses they interact with and companies are responding.

time-read
2 Minuten  |
December 20, 2024
RULES OF ENGAGEMENT
Newsweek US

RULES OF ENGAGEMENT

THE WORKPLACE IS BECOMING A BATTLEGROUND OVER POLARIZED OPINIONS. BUSINESS LEADERS NEED TO GET BETTER AT MANAGING DISPUTES

time-read
10+ Minuten  |
December 20, 2024
John David Washington
Newsweek US

John David Washington

FOR JOHN DAVID WASHINGTON, BRINGING NETFLIX'S THE PIANO LESSON (November 22) from stage to screen was a family affair.

time-read
1 min  |
December 06-13, 2024
A Walk in the Parks
Newsweek US

A Walk in the Parks

Jim O'Heir shares his memories of the hit NBC mockumentary and its cast's hopes of a reunion

time-read
4 Minuten  |
December 06-13, 2024
Philomena Cunk
Newsweek US

Philomena Cunk

PHILOMENA CUNK IS JUST AS SURPRISED AS anyone else at her own popularity.

time-read
1 min  |
December 06-13, 2024